Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Biotransformation of quinazoline and phthalazine by Aspergillus niger.

Sutherland JB, Heinze TM, Schnackenberg LK, Freeman JP, Williams AJ.

J Biosci Bioeng. 2011 Mar;111(3):333-5. doi: 10.1016/j.jbiosc.2010.11.017. Epub 2010 Dec 18.

PMID:
21169055
2.
3.

High speed liquid crystal over silicon display based on the flexoelectro-optic effect.

Chen J, Morris SM, Wilkinson TD, Freeman JP, Coles HJ.

Opt Express. 2009 Apr 27;17(9):7130-7.

PMID:
19399089
4.

Biotransformation of acridine by Mycobacterium vanbaalenii.

Sutherland JB, Heinze TM, Pearce MG, Deck J, Williams AJ, Freeman JP.

Environ Toxicol Chem. 2009 Jan;28(1):61-4. doi: 10.1897/08-206.1.

PMID:
18717621
5.

Effect of Aloe vera whole leaf extract on short chain fatty acids production by Bacteroides fragilis, Bifidobacterium infantis and Eubacterium limosum.

Pogribna M, Freeman JP, Paine D, Boudreau MD.

Lett Appl Microbiol. 2008 May;46(5):575-80. doi: 10.1111/j.1472-765X.2008.02346.x. Epub 2008 Mar 18.

6.

Rapid assessment of postfire plant invasions in coniferous forests of the western United States.

Freeman JP, Stohlgren TJ, Hunter ME, Omi PN, Martinson EJ, Chong GW, Brown CS.

Ecol Appl. 2007 Sep;17(6):1656-65.

PMID:
17913130
7.

Acetylation and nitrosation of ciprofloxacin by environmental strains of mycobacteria.

Adjei MD, Heinze TM, Deck J, Freeman JP, Williams AJ, Sutherland JB.

Can J Microbiol. 2007 Jan;53(1):144-7.

PMID:
17496960
8.

A polyomic approach to elucidate the fluoranthene-degradative pathway in Mycobacterium vanbaalenii PYR-1.

Kweon O, Kim SJ, Jones RC, Freeman JP, Adjei MD, Edmondson RD, Cerniglia CE.

J Bacteriol. 2007 Jul;189(13):4635-47. Epub 2007 Apr 20.

9.

Identification of metabolites produced from N-phenylpiperazine by Mycobacterium spp.

Adjei MD, Deck J, Heinze TM, Freeman JP, Williams AJ, Sutherland JB.

J Ind Microbiol Biotechnol. 2007 Mar;34(3):219-24. Epub 2006 Dec 22.

PMID:
17186210
10.

Biotransformation of flumequine by the fungus Cunninghamella elegans.

Williams AJ, Deck J, Freeman JP, Paul Chiarelli M, Adjei MD, Heinze TM, Sutherland JB.

Chemosphere. 2007 Feb;67(2):240-3. Epub 2006 Nov 22.

PMID:
17123578
11.

Complete and integrated pyrene degradation pathway in Mycobacterium vanbaalenii PYR-1 based on systems biology.

Kim SJ, Kweon O, Jones RC, Freeman JP, Edmondson RD, Cerniglia CE.

J Bacteriol. 2007 Jan;189(2):464-72. Epub 2006 Nov 3.

12.

Transformation of the antibacterial agent norfloxacin by environmental mycobacteria.

Adjei MD, Heinze TM, Deck J, Freeman JP, Williams AJ, Sutherland JB.

Appl Environ Microbiol. 2006 Sep;72(9):5790-3.

13.

In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum).

Jhoo JW, Freeman JP, Heinze TM, Moody JD, Schnackenberg LK, Beger RD, Dragull K, Tang CS, Ang CY.

J Agric Food Chem. 2006 Apr 19;54(8):3157-62.

PMID:
16608246
14.

The effect of the corticosteroid hormone cortexolone on the metabolites produced during phenanthrene biotransformation in Cunninghamella elegans.

Lisowska K, Długoński J, Freeman JP, Cerniglia CE.

Chemosphere. 2006 Aug;64(9):1499-506. Epub 2006 Feb 28.

PMID:
16504243
15.
16.

Molecular characterization of cytochrome P450 genes in the polycyclic aromatic hydrocarbon degrading Mycobacterium vanbaalenii PYR-1.

Brezna B, Kweon O, Stingley RL, Freeman JP, Khan AA, Polek B, Jones RC, Cerniglia CE.

Appl Microbiol Biotechnol. 2006 Jul;71(4):522-32. Epub 2005 Nov 30. Erratum in: Appl Microbiol Biotechnol. 2006 Oct;72(6):1340.

PMID:
16317545
17.

Degradation of benz[a]anthracene by Mycobacterium vanbaalenii strain PYR-1.

Moody JD, Freeman JP, Cerniglia CE.

Biodegradation. 2005 Dec;16(6):513-26.

PMID:
15865344
18.

Fungal biotransformation of benzo[f]quinoline, benzo[h]quinoline, and phenanthridine.

Sutherland JB, Cross EL, Heinze TM, Freeman JP, Moody JD.

Appl Microbiol Biotechnol. 2005 May;67(3):405-11. Epub 2004 Oct 9.

PMID:
15856220
19.

Quantitation of carcinogenic heterocyclic aromatic amines and detection of novel heterocyclic aromatic amines in cooked meats and grill scrapings by HPLC/ESI-MS.

Turesky RJ, Taylor J, Schnackenberg L, Freeman JP, Holland RD.

J Agric Food Chem. 2005 Apr 20;53(8):3248-58.

PMID:
15826085
20.

Photodecomposition of retinyl palmitate in ethanol by UVA light-formation of photodecomposition products, reactive oxygen species, and lipid peroxides.

Cherng SH, Xia Q, Blankenship LR, Freeman JP, Wamer WG, Howard PC, Fu PP.

Chem Res Toxicol. 2005 Feb;18(2):129-38.

PMID:
15720116
21.

Effects of pH on the degradation of phenanthrene and pyrene by Mycobacterium vanbaalenii PYR-1.

Kim YH, Freeman JP, Moody JD, Engesser KH, Cerniglia CE.

Appl Microbiol Biotechnol. 2005 Apr;67(2):275-85. Epub 2004 Dec 9.

PMID:
15592827
22.

Evidence for the existence of PAH-quinone reductase and catechol-O-methyltransferase in Mycobacterium vanbaalenii PYR-1.

Kim YH, Moody JD, Freeman JP, Brezna B, Engesser KH, Cerniglia CE.

J Ind Microbiol Biotechnol. 2004 Dec;31(11):507-16. Epub 2004 Nov 11.

PMID:
15549609
23.

Instability of St. John's wort (Hypericum perforatum L.) and degradation of hyperforin in aqueous solutions and functional beverage.

Ang CY, Hu L, Heinze TM, Cui Y, Freeman JP, Kozak K, Luo W, Liu FF, Mattia A, DiNovi M.

J Agric Food Chem. 2004 Oct 6;52(20):6156-64.

PMID:
15453681
24.

Rapid biomonitoring of heterocyclic aromatic amines in human urine by tandem solvent solid phase extraction liquid chromatography electrospray ionization mass spectrometry.

Holland RD, Taylor J, Schoenbachler L, Jones RC, Freeman JP, Miller DW, Lake BG, Gooderham NJ, Turesky RJ.

Chem Res Toxicol. 2004 Aug;17(8):1121-36.

PMID:
15310244
25.

Degradation of benzo[a]pyrene by Mycobacterium vanbaalenii PYR-1.

Moody JD, Freeman JP, Fu PP, Cerniglia CE.

Appl Environ Microbiol. 2004 Jan;70(1):340-5.

26.

Identification of aminobiphenyl derivatives in commercial hair dyes.

Turesky RJ, Freeman JP, Holland RD, Nestorick DM, Miller DW, Ratnasinghe DL, Kadlubar FF.

Chem Res Toxicol. 2003 Sep;16(9):1162-73.

PMID:
12971805
27.

Synthesis and investigation of alpha-hydroxy-N,N-didesmethyltamoxifen as a proximate carcinogen in the metabolic activation of tamoxifen.

Gamboa da Costa G, Marques MM, Freeman JP, Beland FA.

Chem Res Toxicol. 2003 Sep;16(9):1090-8.

PMID:
12971796
28.

Regio- and stereoselective metabolism of 7,12-dimethylbenz[a]anthracene by Mycobacterium vanbaalenii PYR-1.

Moody JD, Fu PP, Freeman JP, Cerniglia CE.

Appl Environ Microbiol. 2003 Jul;69(7):3924-31.

29.

Quantification of tamoxifen DNA adducts using on-line sample preparation and HPLC-electrospray ionization tandem mass spectrometry.

Gamboa da Costa G, Marques MM, Beland FA, Freeman JP, Churchwell MI, Doerge DR.

Chem Res Toxicol. 2003 Mar;16(3):357-66.

PMID:
12641436
30.

Biotransformation of mirtazapine by Cunninghamella elegans.

Moody JD, Freeman JP, Fu PP, Cerniglia CE.

Drug Metab Dispos. 2002 Nov;30(11):1274-9.

PMID:
12386135
31.

Transformation of cinoxacin by Beauveria bassiana.

Parshikov IA, Moody JD, Heinze TM, Freeman JP, Williams AJ, Sutherland JB.

FEMS Microbiol Lett. 2002 Aug 27;214(1):133-6.

32.

Isolation of an anaerobic intestinal bacterium capable of cleaving the C-ring of the isoflavonoid daidzein.

Hur HG, Beger RD, Heinze TM, Lay JO Jr, Freeman JP, Dore J, Rafii F.

Arch Microbiol. 2002 Jul;178(1):8-12. Epub 2002 Apr 16. Erratum in: Arch Microbiol 2002 Jul;178(1):75.

PMID:
12070764
33.

DNA adducts from nitroreduction of 2,7-dinitrofluorene, a mammary gland carcinogen, catalyzed by rat liver or mammary gland cytosol.

Ritter CL, Culp SJ, Freeman JP, Marques MM, Beland FA, Malejka-Giganti D.

Chem Res Toxicol. 2002 Apr;15(4):536-44.

PMID:
11952340
34.

Degradation of biphenyl by Mycobacterium sp. strain PYR-1.

Moody JD, Doerge DR, Freeman JP, Cerniglia CE.

Appl Microbiol Biotechnol. 2002 Mar;58(3):364-9. Epub 2001 Dec 21.

PMID:
11935189
35.

Oxidation of phenothiazine and phenoxazine by Cunninghamella elegans.

Sutherland JB, Freeman JP, Heinze TM, Moody JD, Parshikov IA, Williams AJ, Zhang D.

Xenobiotica. 2001 Nov;31(11):799-809.

PMID:
11765142
36.

Formation of conjugates from ciprofloxacin and norfloxacin in cultures of Trichoderma viride.

Parshikov IA, Moody JD, Freeman JP, Lay JO Jr, Williams AJ, Heinze TM, Sutherland JB.

Mycologia. 2002 Jan-Feb;94(1):1-5.

PMID:
21156472
37.

Metabolism of anthracene by a Rhodococcus species.

Dean-Ross D, Moody JD, Freeman JP, Doerge DR, Cerniglia CE.

FEMS Microbiol Lett. 2001 Oct 16;204(1):205-11.

38.
39.

The fungus Pestalotiopsis guepini as a model for biotransformation of ciprofloxacin and norfloxacin.

Parshikov IA, Heinze TM, Moody JD, Freeman JP, Williams AJ, Sutherland JB.

Appl Microbiol Biotechnol. 2001 Aug;56(3-4):474-7.

PMID:
11549022
40.

Metabolism of the veterinary fluoroquinolone sarafloxacin by the fungus Mucor ramannianus.

Parshikov IA, Freeman JP, Lay JO Jr, Moody JD, Williams AJ, Beger RD, Sutherland JB.

J Ind Microbiol Biotechnol. 2001 Mar;26(3):140-4.

PMID:
11420653
41.

Biotransformation of vinclozolin by the fungus Cunninghamella elegans.

Pothuluri JV, Freeman JP, Heinze TM, Beger RD, Cerniglia CE.

J Agric Food Chem. 2000 Dec;48(12):6138-48.

PMID:
11312787
42.

Degradation of phenanthrene and anthracene by cell suspensions of Mycobacterium sp. strain PYR-1.

Moody JD, Freeman JP, Doerge DR, Cerniglia CE.

Appl Environ Microbiol. 2001 Apr;67(4):1476-83.

43.

Use of 13C NMR spectrometric data to produce a predictive model of estrogen receptor binding activity.

Beger RD, Freeman JP, Lay JO Jr, Wilkes JG, Miller DW.

J Chem Inf Comput Sci. 2001 Jan-Feb;41(1):219-24.

PMID:
11206376
44.

Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin.

Hur HG, Lay JO Jr, Beger RD, Freeman JP, Rafii F.

Arch Microbiol. 2000 Dec;174(6):422-8.

PMID:
11195098
45.
46.

(13)C NMR and electron ionization mass spectrometric data-activity relationship model of estrogen receptor binding.

Beger RD, Freeman JP, Lay JO Jr, Wilkes JG, Miller DW.

Toxicol Appl Pharmacol. 2000 Nov 15;169(1):17-25.

PMID:
11076692
47.
48.

Potential clinical use of butyric acid derivatives to induce antigen-specific T cell inactivation.

Gilbert KM, Wahid R, Fecher NP, Freeman JP, Fifer EK.

J Pharmacol Exp Ther. 2000 Sep;294(3):1146-53.

PMID:
10945871
49.

Linoleic acid diols are novel substrates for human UDP-glucuronosyltransferases.

Jude AR, Little JM, Freeman JP, Evans JE, Radominska-Pandya A, Grant DF.

Arch Biochem Biophys. 2000 Aug 15;380(2):294-302.

PMID:
10933884
50.

Microbiological transformation of enrofloxacin by the fungus Mucor ramannianus.

Parshikov IA, Freeman JP, Lay JO Jr, Beger RD, Williams AJ, Sutherland JB.

Appl Environ Microbiol. 2000 Jun;66(6):2664-7.

Supplemental Content

Loading ...
Support Center